GlassScriptPhysician profile
Noelle Serrano Cerdan
NPI 1285865774
$1,135.07
in general payments reported to CMS, 2019-2025
13 companies · $316 in 2025
The $316 reported for 2025 was more than what 86% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $150 · 2023: $198 · 2024: $155 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $244.73 | 2021-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Glaxosmithkline, LLC. | $183.68 | 2021-2024 | Bexsero, Pediarix |
| Kowa Pharmaceuticals America, INC. | $163.13 | 2025 | Zoryve |
| Pfizer INC. | $126.57 | 2021-2025 | |
| Sanofi Pasteur INC. | $119.17 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $85.44 | 2021-2024 | Flumist Quadrivalent, Fasenra, Tezspire |
| Seqirus USA INC | $57.80 | 2021-2025 | Flucelvax |
| Kaleo, INC. | $37.32 | 2022 | |
| Cranial Technologies, INC | $33.24 | 2022-2024 | Doc Band |
| Sarepta Therapeutics, INC. | $27.60 | 2024 | |
| Nestle Healthcare Nutrition INC. | $21.52 | 2021 | |
| Avion Pharmaceuticals | $21.31 | 2023 | Methylphenidate Hydrochloride |
| Alk-Abello, INC | $13.56 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noelle Cerdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.